<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xml:lang="EN" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?origin publisher?><?properties no_embargo?><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlm.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Naunyn Schmiedebergs Arch Pharmacol</journal-id><journal-title>Naunyn-Schmiedeberg's Archives of Pharmacology</journal-title><issn pub-type="ppub">0028-1298</issn><issn pub-type="epub">1432-1912</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">434</article-id><article-id pub-id-type="doi">10.1007/s00210-009-0434-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The guinea pig ileum lacks the direct, high-potency, M<sub>2</sub>-muscarinic, contractile mechanism characteristic of the mouse ileum</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Griffin</surname><given-names>Michael T.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Matsui</surname><given-names>Minoru</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ostrom</surname><given-names>Rennolds S.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ehlert</surname><given-names>Frederick J.</given-names></name><address><phone>+1-949-8243709</phone><fax>+1-949-8244855</fax><email>fjehlert@uci.edu</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label>Department of Chemistry, Chapman University, Orange, CA USA </aff><aff id="Aff2"><label>2</label>Department of Pharmacy, Chiba Institute of Science, 15-8 Shiomi-cho, Choshi, Chiba 288-0025 Japan </aff><aff id="Aff3"><label>3</label>Department of Pharmacology, University of Tennessee Health Science Center, Memphis, TN 38163 USA </aff><aff id="Aff4"><label>4</label>Department of Pharmacology, School of Medicine, University of California, Irvine, Irvine, CA 92697-4625 USA </aff></contrib-group><pub-date pub-type="epub"><day>7</day><month>7</month><year>2009</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2009</year></pub-date><volume>380</volume><issue>4</issue><fpage>327</fpage><lpage>335</lpage><history><date date-type="received"><day>5</day><month>5</month><year>2009</year></date><date date-type="rev-recd"><day>11</day><month>6</month><year>2009</year></date><date date-type="accepted"><day>16</day><month>6</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2009</copyright-statement></permissions><abstract xml:lang="EN"><p>We explored whether the M<sub>2</sub> muscarinic receptor in the guinea pig ileum elicits a highly potent, direct-contractile response, like that from the M<sub>3</sub> muscarinic receptor knockout mouse. First, we characterized the irreversible receptor-blocking activity of 4-DAMP mustard in ileum from muscarinic receptor knockout mice to verify its M<sub>3</sub> selectivity. Then, we used 4-DAMP mustard to inactivate M<sub>3</sub> responses in the guinea pig ileum to attempt to reveal direct, M<sub>2</sub> receptor-mediated contractions. The muscarinic agonist, oxotremorine-M, elicited potent contractions in ileum from wild-type, M<sub>2</sub> receptor knockout, and M<sub>3</sub> receptor knockout mice characterized by negative log EC<sub>50</sub> (<italic>pEC</italic><sub><italic>50</italic></sub>) values &#x000b1; SEM of 6.75&#x02009;&#x000b1;&#x02009;0.03, 6.26&#x02009;&#x000b1;&#x02009;0.05, and 6.99&#x02009;&#x000b1;&#x02009;0.08, respectively. The corresponding <italic>E</italic><sub>max</sub> values in wild-type and M<sub>2</sub> receptor knockout mice were approximately the same, but that in the M<sub>3</sub> receptor knockout mouse was only 36% of wild type. Following 4-DAMP mustard treatment, the concentration&#x02013;response curve of oxotremorine-M in wild-type ileum resembled that of the M<sub>3</sub> knockout mouse in terms of its <italic>pEC</italic><sub><italic>50</italic></sub>, <italic>E</italic><sub>max</sub>, and inhibition by selective muscarinic antagonists. Thus, 4-DAMP mustard treatment appears to inactivate M<sub>3</sub> responses selectively and renders the muscarinic contractile behavior of the wild-type ileum similar to that of the M<sub>3</sub> knockout mouse. Following 4-DAMP mustard treatment, the contractile response of the guinea pig ileum to oxotremorine-M exhibited low potency and a competitive-antagonism profile consistent with an M<sub>3</sub> response. The guinea pig ileum, therefore, lacks a direct, highly potent, M<sub>2</sub>-contractile component but may have a direct, lower potency M<sub>2</sub> component.</p></abstract><kwd-group><title>Keywords</title><kwd>Ileum</kwd><kwd>Guinea pig</kwd><kwd>Muscarinic receptor knockout mice</kwd><kwd>4-DAMP mustard</kwd><kwd>M<sub>2</sub> muscarinic receptor</kwd><kwd>M<sub>3</sub> muscarinic receptor</kwd></kwd-group><custom-meta-wrap><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2009</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Subtype selective antagonists inhibit muscarinic contractions of gastrointestinal and urinary bladder smooth muscle in a manner that agrees with an M<sub>3</sub> receptor mechanism (Eglen et al. <xref ref-type="bibr" rid="CR7">1996</xref>). This behavior is consistent with the known coupling of the M<sub>3</sub> receptor to G<sub>q/11</sub> (Noronha-Blob et al. <xref ref-type="bibr" rid="CR19">1989</xref>; Candell et al. <xref ref-type="bibr" rid="CR6">1990</xref>; Roffel et al. <xref ref-type="bibr" rid="CR23">1990</xref>), which is often involved in Ca<sup>2+</sup> mobilization. The details of how M<sub>3</sub>-G<sub>q/11</sub> signaling leads to contraction are unclear, however, because contraction of the guinea pig ileum depends mainly on an extracellular source of Ca<sup>2+</sup> (Bolger et al. <xref ref-type="bibr" rid="CR4">1983</xref>).</p><p>The M<sub>2</sub> muscarinic receptor is also expressed in smooth muscle, and it outnumbers the M<sub>3</sub> by a factor of at least four (Eglen et al. <xref ref-type="bibr" rid="CR7">1996</xref>). The apparent lack of a role of the M<sub>2</sub> receptor in contraction can be explained by the nature of its known signaling mechanisms in smooth muscle (see Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Stimulation of the M<sub>2</sub> receptor activates a nonselective cation conductance; however, the conductance depends on Ca<sup>2+</sup> (Bolton <xref ref-type="bibr" rid="CR5">1979</xref>; Inoue <xref ref-type="bibr" rid="CR14">1991</xref>; Sakamoto et al. <xref ref-type="bibr" rid="CR24">2007</xref>). This explains why there is little increase in conductance unless both the M<sub>2</sub> and the Ca<sup>2+</sup>-mobilizing M<sub>3</sub> receptor are activated simultaneously. The M<sub>2</sub> receptor is also known to inhibit Ca<sup>2+</sup>-activated K<sup>+</sup> channels, which release smooth muscle from inhibitory K<sup>+</sup> currents and enhance contraction (Kotlikoff et al. <xref ref-type="bibr" rid="CR16">1992</xref>). Like the cation conductance, however, this mechanism also requires Ca<sup>2+</sup> mobilization by another receptor to activate the K<sup>+</sup> current before the M<sub>2</sub> receptor can inhibit it. Finally, the M<sub>2</sub> receptor inhibits adenylate cyclase in smooth muscle. This inhibition opposes the relaxant effect of receptors that increase cyclic adenosine monophosphate (cAMP; e.g., &#x003b2;-adrenoceptor; Thomas et al. <xref ref-type="bibr" rid="CR28">1993</xref>; Thomas and Ehlert <xref ref-type="bibr" rid="CR26">1996</xref>; Sawyer and Ehlert <xref ref-type="bibr" rid="CR25">1998</xref>; Ehlert et al. <xref ref-type="bibr" rid="CR10">2005</xref>), and this effect requires Ca<sup>2+</sup> mobilization in the first place; otherwise, there is no contraction to be relaxed by the &#x003b2;-adrenoceptor and no &#x003b2;-adrenoceptor response for the M<sub>2</sub> receptor to inhibit. In trachea, M<sub>2</sub> receptor activation opposes forskolin- but not isoproterenol-induced relaxation, which is consistent with the postulate that the &#x003b2;<sub>2</sub>-adrenoceptor mediates relaxation through a non-cAMP mechanism in the trachea (Ostrom and Ehlert <xref ref-type="bibr" rid="CR20">1998</xref>; <xref ref-type="bibr" rid="CR21">1999</xref>). <table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Summary of the types of contractions elicited by M<sub>2</sub> and M<sub>3</sub> muscarinic receptors in smooth muscle and their putative mechanisms</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Receptor</th><th>Type of contraction</th><th>Tissue and species</th><th>Putative mechanism</th></tr></thead><tbody><tr><td rowspan="5">M<sub>2</sub></td><td>Direct contraction</td><td>Mouse: ileum, trachea, and urinary bladder</td><td>Unknown, G<sub>i</sub> mobilization of extracellular Ca<sup>2+</sup></td></tr><tr><td rowspan="2">Conditional inhibition of cAMP-mediatied relaxation</td><td>Mouse: ileum, trachea, and urinary bladder</td><td rowspan="2">G<sub>i</sub>-mediated inhibition of adenylate cyclase</td></tr><tr><td>Guinea pig: ileum, trachea, colon, and esophagus</td></tr><tr><td rowspan="2">Conditional enhancement of M<sub>3</sub>-receptor-mediated contraction</td><td>Mouse: ileum, urinary bladder, and uterus</td><td rowspan="2">G<sub>i</sub> stimulation of I<sub>cat</sub>; G<sub>i</sub> inhibition of BK<sub>Ca</sub></td></tr><tr><td>Guinea pig: colon and ileum</td></tr><tr><td rowspan="2">M<sub>3</sub></td><td rowspan="2">Direct contraction</td><td rowspan="2">Widespread in guinea pig and mouse smooth muscle</td><td>Major: unknown G<sub>q</sub>-mediated influx of extracellular Ca<sup>2+</sup></td></tr><tr><td>Minor: G<sub>q</sub>-mediated phosphoinositide hydrolysis and release of intracellular Ca<sup>2+</sup></td></tr></tbody></table><table-wrap-foot><p>Contraction is defined as <italic>direct</italic> if activation of the indicated receptor by itself is sufficient to cause contraction. If activation of the receptor subtype by itself has no effect on contraction but elicits or enhances contraction when other receptors are activated, then the muscarinic contraction is defined as <italic>conditional</italic>. Further details are described in the text.</p><p><italic>I</italic><sub><italic>cat</italic></sub> nonselective cation conductance, <italic>BK</italic><sub><italic>Ca</italic></sub> Ca<sup>2+</sup>-activated potassium channel</p></table-wrap-foot></table-wrap></p><p>It may seem that these M<sub>2</sub> effects would be manifest in standard pharmacological antagonism studies. However, we have shown that the competitive antagonism of a response mediated through M<sub>2</sub>&#x02013;M<sub>3</sub> receptor interactions resembles the profile of the directly acting receptor (i.e., the M<sub>3</sub>) and not that of the conditionally acting receptor (i.e., the M<sub>2</sub>; Ehlert <xref ref-type="bibr" rid="CR9">2003</xref>). Thus, the M<sub>3</sub> antagonism profile of standard muscarinic contractions of the ileum and bladder is not inconsistent with the postulate that both M<sub>2</sub> and M<sub>3</sub> receptors interact to elicit contraction.</p><p>Studies on the mouse uterus are consistent with a conditional role for the M<sub>2</sub> receptor in contraction (Kitazawa et al. <xref ref-type="bibr" rid="CR15">2008</xref>). The competitive antagonism of the muscarinic contractile response of wild-type uterus resembles an M<sub>3</sub> profile, but the <italic>E</italic><sub>max</sub> for contraction is inhibited by about 50% in uterus from the M<sub>2</sub> knockout (KO) mouse. In the M<sub>3</sub> KO mouse, muscarinic contractions are absent. Thus, the M<sub>2</sub> receptor is unable to elicit direct contraction of the mouse uterus, but is able to enhance M<sub>3</sub> receptor-mediated contractions.</p><p>Following inactivation of M<sub>3</sub> receptors in guinea pig ileum and colon, we have identified two types of muscarinic contractile responses for the M<sub>2</sub> receptor. One is a highly potent M<sub>2</sub> receptor-mediated inhibition of forskolin- and &#x003b2;-adrenoceptor-mediated relaxation, and the other is a less potent M<sub>2</sub> receptor-mediated enhancement of M<sub>3</sub> receptor contractile signaling (Ehlert <xref ref-type="bibr" rid="CR9">2003</xref>). Circumstantial evidence suggests that the latter is involved in heterologous desensitization, which requires activation of both M<sub>2</sub> and M<sub>3</sub> receptors and is potently antagonized by M<sub>2</sub> selective antagonists (Griffin et al. <xref ref-type="bibr" rid="CR13">2004</xref>).</p><p>Studies on muscarinic receptor knockout mice are consistent with these observations but have revealed an additional, highly potent, direct-contractile mechanism for the M<sub>2</sub> receptor. In M<sub>3</sub> KO mice, the M<sub>2</sub> receptor elicits a highly potent contractile response in ileum and trachea, although the maximum of this response is only about 40% that of the muscarinic contraction in wild-type and M<sub>2</sub> KO tissue (Matsui et al. <xref ref-type="bibr" rid="CR17">2000</xref>; Matsui et al. <xref ref-type="bibr" rid="CR18">2002</xref>).</p><p>In the present study, we have investigated whether a similar, highly potent, direct-M<sub>2</sub>-receptor-mediated contraction occurs in the guinea pig ileum. We show that treatment of the wild-type mouse ileum with 4-DAMP mustard (<italic>N</italic>-2-chloroethyl-4-piperidinyl diphenylacetate) uncovers a highly potent, direct-M<sub>2</sub>-contractile mechanism and converts its pharmacological behavior into that of the M<sub>3</sub> KO mouse. In contrast, treatment of the guinea pig ileum with 4-DAMP mustard caused a large, 56-fold reduction in agonist potency, and the residual muscarinic response exhibited an M<sub>3</sub>-pharmacological profile. Thus, the guinea pig ileum appears to lack the highly potent direct-contractile-M<sub>2</sub> mechanism observed in the mouse. Our data also illustrate that ileal smooth muscle from whole-body M<sub>3</sub> KO mice accurately displays the contractile activity of the M<sub>2</sub> receptor in wild-type mice and that 4-DAMP mustard is a useful tool for inactivating the M<sub>3</sub> responses selectively.</p></sec><sec id="Sec2" sec-type="methods"><title>Methods</title><p><bold>Animals</bold> M<sub>2</sub> muscarinic receptor knockout (M<sub>2</sub>&#x02212;/&#x02212;; M<sub>2</sub> KO) and M<sub>3</sub> muscarinic receptor knockout (M<sub>3</sub>&#x02212;/&#x02212;; M<sub>3</sub> KO) mice were generated as described by Matsui et al. (<xref ref-type="bibr" rid="CR18">2002</xref>).</p><p><bold>Contractile assays in isolated ileal tissue</bold> Contractile measurements were made on ileum from male Hartley guinea pigs (300&#x02013;400&#x000a0;g) and C57Bl-6 mice (25&#x02013;30&#x000a0;g) as described previously (Griffin et al. <xref ref-type="bibr" rid="CR13">2004</xref>). The medium was Krebs&#x02013;Ringer bicarbonate (KRB) buffer (124&#x000a0;mM NaCl, 5&#x000a0;mM KCl, 1.3&#x000a0;mM MgCl<sub>2</sub>, 26&#x000a0;mM NaHCO<sub>3</sub>, 1.2&#x000a0;mM KH<sub>2</sub>PO<sub>4</sub>, 1.8&#x000a0;mM CaCl<sub>2</sub>, 10&#x000a0;mM glucose) containing indomethacin (1&#x000a0;&#x003bc;M) and maintained at 37&#x000b0;C and gassed with O<sub>2</sub>/CO<sub>2</sub> (19:1). Tissues were allowed to incubate for at least an hour and were subsequently challenged with KCl (50&#x000a0;mM) three times, followed by the measurement of a cumulative concentration&#x02013;response curve to oxotremorine-M. This was done to speed up the equilibration of the ileum, which undergoes a time-dependent increase in contractile activity. After appropriate washing, the ileum was incubated for another 30&#x000a0;min prior to the collection of the data presented under &#x0201c;<xref rid="Sec3" ref-type="sec">Results</xref>&#x0201d;. Contractile responses to oxotremorine-M were measured using a cumulative technique. The <italic>E</italic><sub>max</sub> value of oxotremorine-M increased with an increase in age or body weight of each strain of mouse. In addition, the ileal contraction to KCl (50&#x000a0;mM) increased with an increase in body weight but was similar in mice of equivalent body weights across the different strains. All contractions to oxotremorine-M, therefore, were normalized relative to that elicited by KCl (50&#x000a0;mM).</p><p><bold>4-DAMP mustard treatment</bold> A solution of 4-DAMP mustard was first cyclized in 10&#x000a0;mM phosphate buffer, pH 7.4, for 30&#x000a0;min at 37&#x000b0;C to allow formation of the aziridinium ion (Thomas et al. <xref ref-type="bibr" rid="CR27">1992</xref>). The solution was placed on ice and used as soon as possible. Ilea were incubated with 4-DAMP mustard (40&#x000a0;nM) in combination with the M<sub>2</sub> selective antagonist AF-DX 116 (4&#x000a0;&#x003bc;M; [[2-2(diethyl-amino)methyl]-1-piperidinyl]-acetyl]-5,11-dihydro-6H-pyrido[2,3b][1,4] benzodiazepine-6-one) for one or two 1-h time periods, in a final volume of 50&#x000a0;ml of KRB buffer. This minimum volume of medium is essential because 4-DAMP mustard is inactivated by tissue nucleophiles, particularly in substantial tissues like the guinea-pig ileum. After these incubations, the tissue was washed three times and incubated for 30&#x000a0;min prior to contractile measurements.</p><p><bold>Analysis of concentration&#x02013;response curves</bold> Concentration&#x02013;response curves were analyzed using GraphPad Prism software (GraphPad Software, Inc., La Jolla, CA, USA) using the variable slope concentration&#x02013;response curve function. The negative log dissociation constants of antagonists (<italic>pK</italic><sub><italic>B</italic></sub>) were estimated from experiments in which their ability to shift the agonist concentration&#x02013;response curve to the right was measured (Arunlakshana and Schild <xref ref-type="bibr" rid="CR1">1959</xref>):</p><p><disp-formula id="Equa"><tex-math id="M1">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ p{K_B} = - {\text{Log}}\left( {\frac{{\left[ I \right]}}{{{\text{shift}} - 1}}} \right) $$\end{document}</tex-math></disp-formula>In this equation, [<italic>I</italic>] denotes the molar concentration of antagonist, and shift denotes EC<sub>50</sub> value of the agonist measured in the presence of the antagonist divided by that measured in its absence. The Log shift and <italic>pK</italic><sub><italic>B</italic></sub> values were determined for individual experiments and averaged. The significance of differences were evaluated using the unpaired Student's <italic>t</italic> test with the overly conservative Bonferroni adjustment of the critical value of <italic>P</italic> where appropriate.</p><p><bold>Drugs and chemicals</bold> The reagents used in this study were obtained from the following sources: AF-DX 116, Boehringer Ingelheim Pharmaceutical, Ridgefield, CT, USA; oxotremorine-M and indomethacin, Sigma RBI, Natick, MA, USA; 4-DAMP was synthesized using a method similar to that described by Barlow et al. (<xref ref-type="bibr" rid="CR2">1976</xref>), and 4-DAMP mustard was synthesized as described previously (Thomas et al. <xref ref-type="bibr" rid="CR27">1992</xref>).</p></sec><sec id="Sec3" sec-type="results"><title>Results</title><p><bold>Contractile activity of oxotremorine-M in guinea pig and mouse ileum</bold> Oxotremorine-M potently elicited contractions in ilea from both the mouse and guinea pig. The average negative log EC<sub>50</sub> (<italic>pEC</italic><sub><italic>50</italic></sub>) &#x000b1; SEM and <italic>E</italic><sub>max</sub> &#x000b1; SEM values of oxotremorine-M were both greater in guinea pig (7.48&#x02009;&#x000b1;&#x02009;0.05 and 58.2&#x02009;&#x000b1;&#x02009;4.5&#x000a0;mN) than in wild-type mouse (6.75&#x02009;&#x000b1;&#x02009;0.03 and 12.2&#x02009;&#x000b1;&#x02009;0.5&#x000a0;mN). The average responses and their associated SEM values in guinea pig and wild-type mouse were normalized relative to the average <italic>E</italic><sub>max</sub> value of its respective group (i.e., guinea pig or wild-type mouse), and the normalized data are plotted in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. The higher potency of oxotremorine-M in the guinea pig is readily apparent from the figure. The contractile activity of oxotremorine-M was also investigated in ilea from M<sub>2</sub> and M<sub>3</sub> KO mice. The responses in each mouse ileum were first normalized relative to the contraction elicited by KCl (50&#x000a0;mM) as described under &#x0201c;<xref rid="Sec2" ref-type="sec">Methods</xref>.&#x0201d; The mean contractile responses and their respective SEM values were then normalized relative to the <italic>E</italic><sub>max</sub> value of the wild-type mouse. The average <italic>E</italic><sub>max</sub> value &#x000b1; SEM of oxotremorine-M in the M<sub>2</sub> KO mouse ileum (101.2&#x02009;&#x000b1;&#x02009;7.5%) was similar to that of wild type, whereas that measured in the M<sub>3</sub> KO mouse was substantially smaller (35.7&#x02009;&#x000b1;&#x02009;3.5%). Normalization of the muscarinic responses in the mouse to that of KCl did not significantly change the relationship among the <italic>E</italic><sub>max</sub> values in the M<sub>2</sub> KO and M<sub>3</sub> KO strains relative to wild type but did cause a modest reduction in the variance of the mean estimates in wild-type and M<sub>2</sub> KO mice. The potency of oxotremorine-M in the M<sub>2</sub> KO mouse (<italic>pEC</italic><sub><italic>50</italic></sub>&#x02009;=&#x02009;6.26&#x02009;&#x000b1;&#x02009;0.05) was about one third that of the wild-type mouse, whereas that in the M<sub>3</sub> KO mouse (<italic>pEC</italic><sub><italic>50</italic></sub>, 6.99&#x02009;&#x000b1;&#x02009;0.08) was 1.7-fold greater than wild type. These differences in <italic>pEC</italic><sub><italic>50</italic></sub> were significant as indicated in the summary of these data in the legend to Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. Since prior reports have shown that the ileum from the M<sub>2</sub>/M<sub>3</sub> double KO mouse lacks a muscarinic contractile response, the data in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> are consistent with the postulate that the muscarinic contractile response in the wild-type mouse ileum includes a major M<sub>3</sub>-receptor component as well as a minor, but more potent, M<sub>2</sub>-receptor component. Matsui et al. (<xref ref-type="bibr" rid="CR17">2000</xref>; <xref ref-type="bibr" rid="CR18">2002</xref>) have reached a similar conclusion . <fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Contractile activity of oxotremorine-M in ilea from the guinea pig and from wild type, M<sub>2</sub> KO, and M<sub>3</sub> KO mice. The data represent the mean values &#x000b1; SEM from experiments on 13 guinea pigs, 39 wild-type mice, 25 M<sub>2</sub> KO mice, and 25 M<sub>3</sub> KO mice. The responses in the guinea-pig ileum have been normalized relative to <italic>E</italic><sub>max</sub> and those in mice to the <italic>E</italic><sub>max</sub> in wild type</p></caption><graphic position="anchor" xlink:href="210_2009_434_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Contractile activity of oxotremorine-M in guinea pig ileum and in wild-type, M<sub>2</sub> KO, and M<sub>3</sub> KO mouse ileum</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th><italic>pEC</italic><sub><italic>50</italic></sub></th><th><italic>E</italic><sub arrange="stack">max</sub><sup arrange="stack">a</sup> (% wild type)</th><th>Hill slope</th></tr></thead><tbody><tr><td>Guinea pig (13)</td><td char="&#x000b1;" align="char">7.48&#x02009;&#x000b1;&#x02009;0.05<sup>b</sup></td><td char="&#x000b1;" align="char">100&#x02009;&#x000b1;&#x02009;7.7</td><td char="&#x000b1;" align="char">1.38&#x02009;&#x000b1;&#x02009;0.20</td></tr><tr><td colspan="4">Mouse</td></tr><tr><td>&#x000a0;Wild type (39)</td><td char="&#x000b1;" align="char">6.75&#x02009;&#x000b1;&#x02009;0.03</td><td char="&#x000b1;" align="char">100&#x02009;&#x000b1;&#x02009;4.1</td><td char="&#x000b1;" align="char">1.14&#x02009;&#x000b1;&#x02009;0.06</td></tr><tr><td>&#x000a0;M<sub>2</sub> KO (25)</td><td char="&#x000b1;" align="char">6.26&#x02009;&#x000b1;&#x02009;0.05<sup>c</sup></td><td char="&#x000b1;" align="char">101&#x02009;&#x000b1;&#x02009;7.5</td><td char="&#x000b1;" align="char">1.18&#x02009;&#x000b1;&#x02009;0.06</td></tr><tr><td>&#x000a0;M<sub>3</sub> KO (25)</td><td char="&#x000b1;" align="char">6.99&#x02009;&#x000b1;&#x02009;0.08<sup>c</sup></td><td char="&#x000b1;" align="char">35.7&#x02009;&#x000b1;&#x02009;3.5 <sup>d</sup></td><td char="&#x000b1;" align="char">1.18&#x02009;&#x000b1;&#x02009;0.18</td></tr></tbody></table><table-wrap-foot><p>The data are from Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and represent the mean values &#x000b1; SEM. The number of experiments is indicated in parentheses</p><p><sup>a</sup>The <italic>E</italic><sub>max</sub> and SEM values have been normalized relative to the average wild-type <italic>E</italic><sub>max</sub> value for each species.</p><p><sup>b</sup>Significantly different from the <italic>pEC</italic><sub><italic>50</italic></sub> value of wild-type mouse ileum (<italic>P</italic>&#x02009;=&#x02009;4.3&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;16</sup>)</p><p><sup>c</sup>One-way analysis of variance showed highly significant differences among the <italic>pEC</italic><sub><italic>50</italic></sub> values measured in wild type, M<sub>2</sub> KO, and M<sub>3</sub> KO mouse ilea (<italic>F</italic><sub>2,86</sub>&#x02009;=&#x02009;44.14; <italic>P</italic>&#x02009;=&#x02009;6.4&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;14</sup>). Using the unpaired Student's <italic>t</italic> test, the <italic>P</italic> values for differences among the mean <italic>pEC</italic><sub><italic>50</italic></sub> values of wild type and M<sub>2</sub> KO (<italic>P</italic>&#x02009;=&#x02009;3.3&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;11</sup>), wild type and M<sub>3</sub> KO (<italic>P</italic>&#x02009;=&#x02009;0.0054), and M<sub>2</sub> KO and M<sub>3</sub> KO (<italic>P</italic>&#x02009;=&#x02009;2.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;10</sup>) were all less than Bonferroni's adjusted 0.05 value of <italic>P</italic> for three comparisons (0.0167).</p><p><sup>d</sup>Significantly different from the <italic>E</italic><sub>max</sub> of wild-type ileum (<italic>P</italic>&#x02009;=&#x02009;6.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;19</sup>)</p></table-wrap-foot></table-wrap></p><p><bold>Antagonism of the muscarinic response in mouse ileum</bold> We investigated two muscarinic antagonists (AF-DX 116 and 4-DAMP (<italic>N</italic>,<italic>N</italic>-dimethyl-4-piperidinyl diphenylacetate)) with known selectivity for receptor subtypes to determine if their inhibitory action in the mouse ileum is consistent with the picture of M<sub>2</sub> and M<sub>3</sub> receptor function described above in connection with our studies on KO mice. The binding affinities (<italic>pK</italic><sub><italic>D</italic></sub>, negative log dissociation constant) of AF-DX 116 for the human M<sub>2</sub> and M<sub>3</sub> receptor subtypes are 7.27&#x02009;&#x000b1;&#x02009;0.05 and 6.10&#x02009;&#x000b1;&#x02009;0.06, and those of 4-DAMP are 7.87&#x02009;&#x000b1;&#x02009;0.03 and 8.81&#x02009;&#x000b1;&#x02009;0.05, respectively (Esqueda et al. <xref ref-type="bibr" rid="CR11">1996</xref>; Griffin et al. <xref ref-type="bibr" rid="CR13">2004</xref>). Thus, AF-DX 116 exhibits about 15-fold higher affinity for the M<sub>2</sub> receptor relative to M<sub>3</sub>, whereas 4-DAMP exhibits an opposite tenfold selectivity. 4-DAMP actually exhibits high affinity for all subtypes of the muscarinic receptor except the M<sub>2</sub>. We tested each antagonist at a concentration approximately equal to the greater of its two <italic>K</italic><sub><italic>D</italic></sub> values for M<sub>2</sub> and M<sub>3</sub> receptors. With this strategy, the M<sub>2</sub> selective AF-DX 116 and the M<sub>3</sub>-selective 4-DAMP should only cause about twofold shifts in the concentration&#x02013;response curve of an agonist for eliciting M<sub>3</sub> and M<sub>2</sub> responses, respectively, but much greater ten- to 15-fold shifts in responses mediated by the receptors for which they exhibit selectivity (i.e., M<sub>2</sub> and M<sub>3</sub>, respectively).The results of antagonism studies using AF-DX 116 (1&#x000a0;&#x003bc;M) in the mouse ileum from wild-type, M<sub>2</sub> KO, and M<sub>3</sub> KO mice are show in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a&#x02013;c</xref>. In ileum from the M<sub>3</sub> KO mouse (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>), AF-DX 116 caused a 10.5-fold shift in the concentration response curve of oxotremorine-M, which yielded an estimated <italic>pK</italic><sub><italic>B</italic></sub> value of (6.97&#x02009;&#x000b1;&#x02009;0.03) similar to its binding affinity for the M<sub>2</sub> receptor (<italic>pK</italic><sub><italic>D</italic></sub>&#x02009;=&#x02009;7.27&#x02009;&#x000b1;&#x02009;0.05). In contrast, AF-DX 116 only caused 2.6- and 2.7-fold shifts in the concentration response curves of oxotremorine-M in wild-type and M<sub>2</sub> KO mice, respectively. 4-DAMP exhibited the opposite selectivity (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a&#x02013;c</xref>). It caused a 6.8-fold shift in the concentration&#x02013;response curve of oxotremorine-M in the M<sub>2</sub> KO mouse (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>), which yields an estimated <italic>pK</italic><sub><italic>B</italic></sub> value (8.74&#x02009;&#x000b1;&#x02009;0.19) similar to its binding affinity for the M<sub>3</sub> receptor (8.81&#x02009;&#x000b1;&#x02009;0.05, Griffin et al. <xref ref-type="bibr" rid="CR13">2004</xref>). A similar shift of 14-fold was observed in the wild-type mouse (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>), whereas a much smaller shift (1.5-fold) was measured in ilea from the M<sub>3</sub> KO mouse (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>). These results are summarized in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and are consistent with the postulate mentioned above that the muscarinic contractile response in the mouse ileum includes major and minor, directly acting M<sub>3</sub> and M<sub>2</sub> components, respectively. <fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Competitive antagonism of the response to oxotremorine-M by AF-DX 116 (1&#x000a0;&#x003bc;M) and 4-DAMP (10&#x000a0;nM) in ilea from wild type (<bold>a</bold>), M<sub>2</sub> KO (<bold>b</bold>), and M<sub>3</sub> KO (<bold>c</bold>) mice. The data are normalized relative to the <italic>E</italic><sub>max</sub> of control and represent the mean values &#x000b1; SEM from four to seven experiments</p></caption><graphic position="anchor" xlink:href="210_2009_434_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Effects of AF-DX 116 and 4-DAMP on the contractile response to oxotremorine-M in mouse ileum</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="2">AF-DX 116 (1&#x000a0;&#x003bc;M)</th><th colspan="2">4-DAMP (10&#x000a0;nM)</th></tr><tr><th>Log shift<sup>a</sup></th><th><italic>pK</italic><sub><italic>B</italic></sub></th><th>Log shift<sup>a</sup></th><th><italic>pK</italic><sub><italic>B</italic></sub></th></tr></thead><tbody><tr><td>Wild type (7, 7)</td><td char="&#x000b1;" align="char">0.42&#x02009;&#x000b1;&#x02009;0.06</td><td char="&#x000b1;" align="char">6.17&#x02009;&#x000b1;&#x02009;0.14</td><td char="&#x000b1;" align="char">1.16&#x02009;&#x000b1;&#x02009;0.13</td><td>9.12&#x02009;&#x000b1;&#x02009;.14</td></tr><tr><td>M<sub>2</sub> KO (4, 6)</td><td char="&#x000b1;" align="char">0.43&#x02009;&#x000b1;&#x02009;0.18</td><td char="&#x000b1;" align="char">5.93&#x02009;&#x000b1;&#x02009;0.42</td><td char="&#x000b1;" align="char">0.83&#x02009;&#x000b1;&#x02009;0.19</td><td>8.74&#x02009;&#x000b1;&#x02009;.19</td></tr><tr><td>M<sub>3</sub> KO (7, 4)</td><td char="&#x000b1;" align="char">1.02&#x02009;&#x000b1;&#x02009;0.02</td><td char="&#x000b1;" align="char">6.97&#x02009;&#x000b1;&#x02009;0.03</td><td char="&#x000b1;" align="char">0.18&#x02009;&#x000b1;&#x02009;0.17</td><td>n.d.<sup>b</sup></td></tr></tbody></table><table-wrap-foot><p>The data are from Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and represent the mean values &#x000b1; SEM. The two numbers in parentheses beside each mouse strain denote the number of experiments done with AF-DX 116 and 4-DAMP, respectively</p><p><sup>a</sup>The Log shift denotes the logarithm of the ratio of the EC<sub>50</sub> value measured in the presence of the antagonist divided by that measured in its absence</p><p><sup>b</sup>The <italic>pK</italic><sub><italic>B</italic></sub> was not determined because of the low log shift value</p></table-wrap-foot></table-wrap>We also investigated the effects of 4-DAMP mustard on the muscarinic contractile response of the mouse ileum (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). At neutral pH, 4-DAMP mustard forms an aziridinium ion that binds covalently to muscarinic receptors. When used at a concentration of 40&#x000a0;nM in the presence of AF-DX 116 (4&#x000a0;&#x003bc;M) for 1&#x000a0;h at 37&#x000b0;C, 4-DAMP mustard inactivates 96% of human M<sub>3</sub> receptors expressed in CHO cells but only 22% of human M<sub>2</sub> receptors (Griffin et al. <xref ref-type="bibr" rid="CR12">2003</xref>). Isolated ilea from wild-type, M<sub>2</sub> KO, and M<sub>3</sub> KO mice were incubated, with 4-DAMP mustard (40&#x000a0;nM) in combination with AF-DX 116 (4&#x000a0;&#x003bc;M) for a total time of 2&#x000a0;h, and washed extensively (see &#x0201c;<xref rid="Sec2" ref-type="sec">Methods</xref>&#x0201d;). This treatment reduced the <italic>E</italic><sub>max</sub> value of oxotremorine-M in wild-type mouse ileum to only 43% of control while having little effect on EC<sub>50</sub>. As shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref>, the residual response in wild-type ileum after 4-DAMP mustard treatment was nearly identical to that measured in the untreated ileum from the M<sub>3</sub> KO mouse. Similar results were obtained when the incubation with 4-DAMP mustard only lasted 1&#x000a0;h (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Treatment with 4-DAMP mustard (2&#x000a0;h) caused a large inhibition in the response to oxotremorine-M in the M<sub>2</sub> KO mouse ileum (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>), but had little effect on the response in the M<sub>3</sub> KO ileum (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3c</xref>). The results are consistent with the postulate that 4-DAMP mustard treatment selectively inactivates M<sub>3</sub> responses over M<sub>2</sub>, thereby converting the muscarinic behavior of the wild-type ileum into that of the M<sub>3</sub> KO ileum. These results are summarized in Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>. <fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Effects of 4-DAMP mustard treatment on contractions elicited to oxotremorine-M in mouse ileum. <bold>a</bold> Responses were measured in ilea from the M<sub>3</sub> KO mouse (<italic>open triangles</italic>) and from wild-type ileum before (<italic>open circles</italic>) and after (<italic>closed triangles</italic>) treatment with 4-DAMP mustard (40&#x000a0;nM) in combination with AF-DX 116 (4&#x000a0;&#x003bc;M) for 2&#x000a0;h followed by washing as described under &#x0201c;<xref rid="Sec2" ref-type="sec">Methods</xref>.&#x0201d; <bold>b</bold> Responses were measured in ilea from the M<sub>2</sub> KO mouse before (<italic>open circles</italic>) and after (<italic>closed triangles</italic>) treatment with 4-DAMP mustard as described in <bold>a</bold>. <bold>c</bold> Same as <bold>b</bold> except that responses were measured in ilea from the M<sub>3</sub> KO mouse. <bold>d</bold> All responses were measured in ilea from wild-type mice that had been treated with 4-DAMP mustard as described in <bold>a</bold>. After this treatment, responses were measured in the absence (<italic>open circles</italic>) and presence of AF-DX 116 (1&#x000a0;&#x003bc;M; <italic>closed triangles</italic>) or 4-DAMP (10&#x000a0;nM; <italic>open triangles</italic>). Mean values &#x000b1; SEM from five to seven experiments are plotted in <bold>a</bold>&#x02013;<bold>d</bold></p></caption><graphic position="anchor" xlink:href="210_2009_434_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Effect of 4-DAMP mustard treatment (40&#x000a0;nM) in combination with AF-DX 116 (4&#x000a0;&#x003bc;M) on the contractile activity of oxotremorine-M in mouse ileum</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th>Control</th><th colspan="2">4-DAMP mustard</th></tr><tr><th><italic>pEC</italic><sub><italic>50</italic></sub></th><th><italic>pEC</italic><sub><italic>50</italic></sub></th><th><italic>E</italic><sub>max</sub> (%)<sup>a</sup></th></tr></thead><tbody><tr><td colspan="4">Wild type</td></tr><tr><td>1&#x000a0;h treatment (9)</td><td char="&#x000b1;" align="char">6.59&#x02009;&#x000b1;&#x02009;0.08</td><td char="&#x000b1;" align="char">6.62&#x02009;&#x000b1;&#x02009;0.17</td><td char="&#x000b1;" align="char">34&#x02009;&#x000b1;&#x02009;8</td></tr><tr><td>2&#x000a0;h treatment (7)</td><td char="&#x000b1;" align="char">6.96&#x02009;&#x000b1;&#x02009;0.06</td><td char="&#x000b1;" align="char">6.89&#x02009;&#x000b1;&#x02009;0.14</td><td char="&#x000b1;" align="char">43&#x02009;&#x000b1;&#x02009;9</td></tr><tr><td colspan="4">M<sub>2</sub> KO</td></tr><tr><td>2&#x000a0;h treatment (6)</td><td char="&#x000b1;" align="char">6.39&#x02009;&#x000b1;&#x02009;0.09</td><td char="&#x000b1;" align="char">5.80&#x02009;&#x000b1;&#x02009;0.16</td><td char="&#x000b1;" align="char">33&#x02009;&#x000b1;&#x02009;9</td></tr><tr><td colspan="4">M<sub>3</sub> KO</td></tr><tr><td>2&#x000a0;h treatment (5)</td><td char="&#x000b1;" align="char">7.15&#x02009;&#x000b1;&#x02009;0.08</td><td char="&#x000b1;" align="char">7.36&#x02009;&#x000b1;&#x02009;0.09</td><td char="&#x000b1;" align="char">74&#x02009;&#x000b1;&#x02009;3</td></tr></tbody></table><table-wrap-foot><p>The data are from Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> and represent the mean values &#x000b1; SEM. The numbers in parentheses beside each mouse strain denote the number of experiments. The <italic>E</italic><sub>max</sub> values in 4-DAMP mustard-treated ileum are normalized relative to that measured under control conditions</p><p><sup>a</sup><italic>E</italic><sub>max</sub> values and their SEM have been normalized relative to the average <italic>E</italic><sub>max</sub> value of control</p></table-wrap-foot></table-wrap>To obtain further support for this hypothesis, we characterized the pharmacological profile of the muscarinic response in 4-DAMP mustard-treated wild-type ileum using the competitive antagonists, 4-DAMP and AF-DX 116. After 4-DAMP mustard treatment, AF-DX 116 (1&#x000a0;&#x003bc;M) and 4-DAMP (10&#x000a0;nM) caused 9.8- and 3.0-fold shifts in the concentration response curve to oxotremorine-M in wild-type mouse ileum, yielding <italic>pK</italic><sub><italic>B</italic></sub> estimates of 6.90&#x02009;&#x000b1;&#x02009;0.13 and 8.30&#x02009;&#x000b1;&#x02009;0.28, respectively (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3d</xref>). This profile of antagonism is similar to that described above for the ileum from M<sub>3</sub> KO mice (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>).</p><p><bold>Characterization of the muscarinic contractile response in guinea pig ileum</bold> The effects of AF-DX 116 (1&#x000a0;&#x003bc;M) and 4-DAMP (10&#x000a0;nM) on the contractile response to oxotremorine-M in the guinea pig ileum are shown in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a</xref>. These two antagonists caused shifts of 3.1- and tenfold, respectively, in the concentration&#x02013;response curve. This behavior is consistent with the well-known M<sub>3</sub> profile of this tissue, yielding <italic>pK</italic><sub><italic>B</italic></sub>&#x02009;&#x000b1;&#x02009;SEM values of 6.28&#x02009;&#x000b1;&#x02009;0.10 and 9.00&#x02009;&#x000b1;&#x02009;0.06 for AF-DX 116 and 4-DAMP, respectively, in excellent agreement with the binding affinity for the human M<sub>3</sub> receptor. Treatment of the guinea pig ileum with 4-DAMP mustard (40&#x000a0;nM) in combination with AF-DX 116 (4&#x000a0;&#x003bc;M) for 2&#x000a0;h followed by washing caused a 56-fold dextral shift in the concentration&#x02013;response curve to oxotremorine-M, with a small increase in its <italic>E</italic><sub>max</sub> value (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4b</xref>). This small effect can be attributed to time, since we observed time-dependent increases in <italic>E</italic><sub>max</sub> with repetitive measurement of concentration&#x02013;response curves to oxotremorine-M. Unlike the behavior observed in wild-type mouse ileum, treatment of the guinea pig ileum with 4-DAMP mustard did not uncover a direct, highly potent contraction with a low <italic>E</italic><sub>max</sub> value. Following 4-DAMP mustard treatment, the effects of AF-DX 116 (1.3-fold dextral shift) and 4-DAMP (4.3-fold dextral shift) on the EC<sub>50</sub> value of oxotremorine-M in the guinea pig ileum where qualitatively similar to those measured before 4-DAMP mustard treatment and, hence, suggestive of a direct M<sub>3</sub> mechanism. Control experiments showed that the potency of oxotremorine-M increased 1.45-fold 1&#x000a0;h after 4-DAMP mustard treatment, suggesting that the measured antagonist-induced shifts were underestimated. Correcting these measured shifts by a factor of 1.45 yields theoretical shifts of 1.89 and 6.21 for AF-DX 116 (1&#x000a0;&#x003bc;M) and 4-DAMP (10&#x000a0;nM), respectively, which yield <italic>pK</italic><sub><italic>B</italic></sub> values of 5.94 and 8.72 for these antagonists. <fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Effects of AF-DX 116 (1&#x000a0;&#x003bc;M) and 4-DAMP (10&#x000a0;nM) before (<bold>a</bold>) and after (<bold>b</bold>) 4-DAMP mustard treatment on contractile responses to oxotremorine-M in the guinea pig ileum. <bold>a</bold> Responses were measured in the absence (<italic>open symbols</italic>) and presence of AF-DX 116 (<italic>closed triangles</italic>) or 4-DAMP (<italic>open triangles</italic>). <bold>b</bold> Responses were first measured under control conditions (<italic>open circles</italic>). After 4-DAMP mustard treatment and washing, responses were measured in the absence (<italic>closed triangles</italic>) and presence of AF-DX 116 (<italic>closed diamonds</italic>) or 4-DAMP (<italic>open triangles</italic>). Ilea were treated with 4-DAMP mustard (40&#x000a0;nM) for 1&#x000a0;h in the presence of AF-DX 116 (4&#x000a0;&#x003bc;M) and were then washed three times as described under &#x0201c;<xref rid="Sec2" ref-type="sec">Methods</xref>.&#x0201d; The data in <bold>a</bold> and <bold>b</bold> represent the mean response values &#x000b1; SEM from ten to 13 experiments</p></caption><graphic position="anchor" xlink:href="210_2009_434_Fig4_HTML" id="MO4"/></fig></p></sec><sec id="Sec4" sec-type="discussion"><title>Discussion</title><p>Muscarinic agonists elicit contraction in isolated ileum, trachea, and urinary bladder from many mammals, including the mouse. This function undergoes small, large, and complete losses in the M<sub>2</sub> KO, M<sub>3</sub> KO, and M<sub>2</sub>/M<sub>3</sub> double KO mice, respectively (Matsui et al. <xref ref-type="bibr" rid="CR17">2000</xref>; Matsui et al. <xref ref-type="bibr" rid="CR18">2002</xref>), showing that M<sub>2</sub> and M<sub>3</sub> receptors account for contraction and that, in the absence of other agents, the latter contributes more to the response than the former. Contractions to efficacious muscarinic agonists are insensitive to tetrodotoxin, indicating that the relevant M<sub>2</sub> and M<sub>3</sub> receptors are located postjunctionally (Unno et al. <xref ref-type="bibr" rid="CR30">2005</xref>). Muscarinic agonists display high potency for eliciting contraction through the M<sub>2</sub> receptor in smooth muscle from the M<sub>3</sub> KO mouse, yet compared to that measured in wild-type tissue, their <italic>E</italic><sub>max</sub> values are only 10% in urinary bladder and 30&#x02013;40% in ileum and trachea (Matsui et al. <xref ref-type="bibr" rid="CR17">2000</xref>). Direct M<sub>2</sub> receptor-mediated contractions in the ileum from the M<sub>3</sub> KO mouse have been reported to be evanescent (Unno et al. <xref ref-type="bibr" rid="CR30">2005</xref>), although we have found them to be reasonably stable over the time required to measure data for a cumulative, concentration&#x02013;response curve. These contractions are pertussis toxin-sensitive and inhibited completely by the voltage-dependent Ca<sup>2+</sup> antagonist, nicardipine (Unno et al. <xref ref-type="bibr" rid="CR30">2005</xref>). In contrast, M<sub>3</sub> receptor-mediated contractions are pertussis toxin-insensitive and are partially inhibited by nicardipine in mouse (Unno et al. <xref ref-type="bibr" rid="CR30">2005</xref>) but nearly completely inhibited by voltage-sensitive Ca<sup>2+</sup> channel blockers in guinea pig (Bolger et al. <xref ref-type="bibr" rid="CR4">1983</xref>).</p><p>The first report (Matsui et al. <xref ref-type="bibr" rid="CR17">2000</xref>) of a directly mediated M<sub>2</sub> contraction in the M<sub>3</sub> KO mouse was surprising because prior studies on the guinea pig had not uncovered such a role, although clear evidence for conditional M<sub>2</sub> responses&#x02014;that is, those dependent on other receptors&#x02014;had been observed. It might be argued that the direct M<sub>2</sub> effect had gone unnoticed in guinea pigs because the antagonists used to characterize contraction lacked the requisite selectivity for muscarinic receptor subtypes to detect a small M<sub>2</sub> effect. This raises the question of whether the direct contractile role of the M<sub>2</sub> receptor was missed in the guinea pig or whether guinea pigs simply differ from mice in their lack of this potent M<sub>2</sub> function. For these reasons, we investigated whether it is possible to convert the muscarinic response of the ileum from the wild-type mouse into that of the M<sub>3</sub> KO using 4-DAMP mustard and, if so, whether this treatment reveals a direct M<sub>2</sub> receptor-mediated contraction in the guinea pig.</p><p>The compound, 4-DAMP mustard, is a nitrogen mustard derivative that cyclizes spontaneously into a reactive aziridinium ion nearly identical to the competitive muscarinic antagonist 4-DAMP except for its lack of two hydrogen atoms (Barlow et al. <xref ref-type="bibr" rid="CR3">1990</xref>). The latter compound only exhibits about tenfold higher affinity for the M<sub>3</sub> receptor over the M<sub>2</sub>. At 100% receptor occupancy, 4-DAMP mustard alkylates M<sub>2</sub> and M<sub>3</sub> receptors at a similar rate (rate constant, 0.1&#x000a0;min<sup>&#x02212;1</sup>; half time, 7&#x000a0;min), but selectivity for the M<sub>3</sub> receptor can be achieved at the cost of a slower rate of alkylation by using a lower concentration of the aziridinium ion or by adding a competitive, M<sub>2</sub>-selective antagonist (e.g., AF-DX 116) to the incubation (Thomas et al. <xref ref-type="bibr" rid="CR27">1992</xref>). Using 4-DAMP mustard (40&#x000a0;nM) in combination with AF-DX 116 (4&#x000a0;&#x003bc;M) for 1&#x000a0;h, we showed that it is possible to alkylate 96% of a population of the human M<sub>3</sub> receptor expressed in CHO cells, while only inactivating 22% of human M<sub>2</sub> receptors (Griffin et al. <xref ref-type="bibr" rid="CR12">2003</xref>).</p><p>Treatment of the wild-type mouse ileum with 4-DAMP mustard reduced the <italic>E</italic><sub>max</sub> of the contractile response to oxotremorine-M by about 60% while having little effect on EC<sub>50</sub>. The residual concentration&#x02013;response curve resembled that measured in the M<sub>3</sub> KO mouse, in terms of its EC<sub>50</sub>, <italic>E</italic><sub>max</sub>, and antagonism by AF-DX 116 and 4-DAMP. These compounds had <italic>pK</italic><sub><italic>B</italic></sub> values of 6.90 and 8.30, respectively, that differed by only about 0.4 log units from their binding affinities (<italic>pK</italic><sub><italic>D</italic></sub>) for human M<sub>2</sub> receptors (7.27 and 7.87 (Esqueda et al. <xref ref-type="bibr" rid="CR11">1996</xref>; Griffin et al. <xref ref-type="bibr" rid="CR13">2004</xref>)). The difference may be ascribed to recycling of muscarinic receptors after 4-DAMP mustard treatment as discussed below. In contrast, the <italic>pK</italic><sub><italic>B</italic></sub> values of the same compounds in wild-type mouse ileum (6.17 and 9.12) are similar to their respective binding affinities (<italic>pK</italic><sub><italic>D</italic></sub>) for the M<sub>3</sub> receptor (6.10 and 8.81 (Esqueda et al. <xref ref-type="bibr" rid="CR11">1996</xref>; Griffin et al. <xref ref-type="bibr" rid="CR13">2004</xref>)). The direct M<sub>2</sub>-component of contraction in the wild-type mouse does not significantly perturb the antagonism profile of the wild-type response from that expected for a pure M<sub>3</sub> response, illustrating the inability of these antagonists to resolve a minor receptor component of the response. 4-DAMP mustard treatment had little effect on muscarinic contractions in the M<sub>3</sub> KO mouse. Our data suggest that 4-DAMP mustard treatment selectively inactivated M<sub>3</sub> receptors in the wild-type ileum to unmask direct M<sub>2</sub>-receptor-mediated contractions that behaved similarly to those of the M<sub>3</sub> KO mouse.</p><p>In contrast, 4-DAMP mustard treatment completely eliminated the high-potency response of the guinea pig ileum to oxotremorine-M. Only low-potency contractions to oxotremorine-M remained after 4-DAMP mustard treatment, for the concentration&#x02013;response curve shifted to the right about 56-fold with no decline in <italic>E</italic><sub>max</sub>. These low-potency contractions were antagonized by AF-DX 116 and 4-DAMP in a manner qualitatively resembling that expected for an M<sub>3</sub> response. The shift in the concentration&#x02013;response curve caused by the M<sub>2</sub>-selective AF-DX 116 was only one fortieth of that expected for an M<sub>2</sub> response, and that caused by the M<sub>3</sub>-selective 4-DAMP was threefold greater than expected for an M<sub>2</sub> response. Both shifts, however, were about threefold smaller than that expected for an M<sub>3</sub> response. This decrement in antagonism may be explained, in part, by the trafficking of new muscarinic receptors to the plasma membrane after 4-DAMP mustard treatment because control experiments showed about a 1.5-fold increase in the potency of oxotremorine-M during the same time period.</p><p>The guinea pig ileum is exquisitely sensitive to muscarinic agonists, and only a fraction of 1% of the muscarinic receptor population is required for the response at EC<sub>50</sub> (Ringdahl <xref ref-type="bibr" rid="CR22">1984</xref>). A recovery of such a small amount of receptors seems plausible after 4-DAMP mustard treatment and before the response to oxotremorine-M was measured in the presence of antagonist (45&#x02013;60&#x000a0;min). This time was used for washing residual agonist from the tissue and incubating with antagonist. In tissue homogenates, there is no recovery of muscarinic receptor binding after a few hours following 4-DAMP mustard treatment (Thomas et al. <xref ref-type="bibr" rid="CR27">1992</xref>), although the error in this measurement is at the same level as that capable of causing a small leftward shift in the concentration&#x02013;response curve (i.e., about 2% of the receptor population).</p><p>In contrast to that of the guinea pig, the M<sub>3</sub> response of the mouse ileum is much less sensitive to oxotremorine-M. Based on our prior work, it requires approximately 30% receptor occupancy by oxotremorine-M to elicit a 50% contractile response (Tran et al. <xref ref-type="bibr" rid="CR29">2009</xref>). This difference in the sensitivities of the mouse and guinea pig ileum can explain why it was possible to reduce the <italic>E</italic><sub>max</sub> value of oxotremorine-M in both the wild-type and M<sub>2</sub> KO ileum, while the same treatment did not affect the <italic>E</italic><sub>max</sub> in the guinea pig ileum.</p><p>Our inability to detect direct, M<sub>2</sub>-receptor-mediated contractions in the guinea pig ileum does not rule them out; our point is that if they exist, they must be mediated by oxotremorine-M with much less potency than in the mouse or that it requires an agonist with much greater efficacy than oxotremorine-M to detect them. Since relative efficacy of oxotremorine-M is similar to or greater than that of acetylcholine at the M<sub>2</sub> receptor (Ehlert <xref ref-type="bibr" rid="CR8">1985</xref>; Tran et al. <xref ref-type="bibr" rid="CR29">2009</xref>), our data show that highly potent, direct M<sub>2</sub>-receptor-mediated contractions are not mediated by acetylcholine physiologically. Thus, although the M<sub>2</sub> receptor of the guinea pig ileum mediates a high potency inhibition of relaxation and a low potency enhancement of M<sub>3</sub> receptor-mediated contractions (Ehlert <xref ref-type="bibr" rid="CR9">2003</xref>), it does not mediate a high potency direct contraction like that of the mouse ileum.</p></sec></body><back><ack><p>This work was supported by grant number HL079166 from the National Institutes of Health (RSO).</p><p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arunlakshana</surname><given-names>O</given-names></name><name><surname>Schild</surname><given-names>HO</given-names></name></person-group><article-title>Some quantitative uses of drug antagonists</article-title><source>Brit J Pharmacol</source><year>1959</year><volume>14</volume><fpage>48</fpage><lpage>58</lpage></citation><citation citation-type="display-unstructured">Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Brit J Pharmacol 14:48&#x02013;58 <pub-id pub-id-type="pmid">13651579</pub-id></citation></ref><ref id="CR2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>RB</given-names></name><name><surname>Berry</surname><given-names>KJ</given-names></name><name><surname>Glenton</surname><given-names>PA</given-names></name><name><surname>Nilolaou</surname><given-names>NM</given-names></name><name><surname>Soh</surname><given-names>KS</given-names></name></person-group><article-title>A comparison of affinity constants for muscarine-sensitive acetylcholine receptors in guinea-pig atrial pacemaker cells at 29&#x000b0;C and in ileum at 29&#x000b0;C and 37&#x000b0;C</article-title><source>Brit J Pharmacol</source><year>1976</year><volume>58</volume><fpage>613</fpage><lpage>620</lpage></citation><citation citation-type="display-unstructured">Barlow RB, Berry KJ, Glenton PA, Nilolaou NM, Soh KS (1976) A comparison of affinity constants for muscarine-sensitive acetylcholine receptors in guinea-pig atrial pacemaker cells at 29&#x000b0;C and in ileum at 29&#x000b0;C and 37&#x000b0;C. Brit J Pharmacol 58:613&#x02013;620 <pub-id pub-id-type="pmid">1000135</pub-id></citation></ref><ref id="CR3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>RB</given-names></name><name><surname>Shepherd</surname><given-names>MK</given-names></name><name><surname>Veale</surname><given-names>MA</given-names></name></person-group><article-title>Some differential effects of 4-diphenylacetoxy-<italic>N</italic>-(2-chloroethyl)-piperidine hydrochloride on guinea-pig atria and ileum</article-title><source>J Pharm Pharmacol</source><year>1990</year><volume>42</volume><fpage>412</fpage><lpage>418</lpage></citation><citation citation-type="display-unstructured">Barlow RB, Shepherd MK, Veale MA (1990) Some differential effects of 4-diphenylacetoxy-N-(2-chloroethyl)-piperidine hydrochloride on guinea-pig atria and ileum. J Pharm Pharmacol 42:412&#x02013;418 <pub-id pub-id-type="pmid">1979621</pub-id></citation></ref><ref id="CR4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolger</surname><given-names>GT</given-names></name><name><surname>Gengo</surname><given-names>P</given-names></name><name><surname>Klockowski</surname><given-names>R</given-names></name><name><surname>Luchowski</surname><given-names>E</given-names></name><name><surname>Siegel</surname><given-names>H</given-names></name><name><surname>Janis</surname><given-names>RA</given-names></name><name><surname>Triggle</surname><given-names>AM</given-names></name><name><surname>Triggle</surname><given-names>DJ</given-names></name></person-group><article-title>Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle</article-title><source>J Pharmacol Exp Ther</source><year>1983</year><volume>225</volume><fpage>291</fpage><lpage>309</lpage></citation><citation citation-type="display-unstructured">Bolger GT, Gengo P, Klockowski R, Luchowski E, Siegel H, Janis RA, Triggle AM, Triggle DJ (1983) Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. J Pharmacol Exp Ther 225:291&#x02013;309 <pub-id pub-id-type="pmid">6842393</pub-id></citation></ref><ref id="CR5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolton</surname><given-names>TB</given-names></name></person-group><article-title>Mechanisms of action of transmitters and other substances on smooth muscle</article-title><source>Physiol Rev</source><year>1979</year><volume>59</volume><fpage>606</fpage><lpage>718</lpage></citation><citation citation-type="display-unstructured">Bolton TB (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59:606&#x02013;718 <pub-id pub-id-type="pmid">37533</pub-id></citation></ref><ref id="CR6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Candell</surname><given-names>LM</given-names></name><name><surname>Yun</surname><given-names>SH</given-names></name><name><surname>Tran</surname><given-names>LL</given-names></name><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum</article-title><source>Mol Pharmacol</source><year>1990</year><volume>38</volume><fpage>689</fpage><lpage>697</lpage></citation><citation citation-type="display-unstructured">Candell LM, Yun SH, Tran LL, Ehlert FJ (1990) Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum. Mol Pharmacol 38:689&#x02013;697 <pub-id pub-id-type="pmid">2172776</pub-id></citation></ref><ref id="CR7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eglen</surname><given-names>RM</given-names></name><name><surname>Hegde</surname><given-names>SS</given-names></name><name><surname>Watson</surname><given-names>N</given-names></name></person-group><article-title>Muscarinic receptor subtypes and smooth muscle function</article-title><source>Pharmacol Rev</source><year>1996</year><volume>48</volume><fpage>531</fpage><lpage>565</lpage></citation><citation citation-type="display-unstructured">Eglen RM, Hegde SS, Watson N (1996) Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 48:531&#x02013;565 <pub-id pub-id-type="pmid">8981565</pub-id></citation></ref><ref id="CR8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium</article-title><source>Mol Pharmacol</source><year>1985</year><volume>28</volume><fpage>410</fpage><lpage>421</lpage></citation><citation citation-type="display-unstructured">Ehlert FJ (1985) The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium. Mol Pharmacol 28:410&#x02013;421 <pub-id pub-id-type="pmid">4058422</pub-id></citation></ref><ref id="CR9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>Pharmacological analysis of the contractile role of M<sub>2</sub> and M<sub>3</sub> muscarinic receptor in smooth muscle</article-title><source>Receptors Channels</source><year>2003</year><volume>9</volume><fpage>261</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1080/10606820308265</pub-id></citation><citation citation-type="display-unstructured">Ehlert FJ (2003) Pharmacological analysis of the contractile role of M2 and M3 muscarinic receptor in smooth muscle. Receptors Channels 9:261&#x02013;277 <pub-id pub-id-type="pmid">12893538</pub-id></citation></ref><ref id="CR10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ehlert</surname><given-names>FJ</given-names></name><name><surname>Griffin</surname><given-names>MT</given-names></name><name><surname>Abe</surname><given-names>DM</given-names></name><name><surname>Vo</surname><given-names>TH</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Manabe</surname><given-names>T</given-names></name><name><surname>Matsui</surname><given-names>M</given-names></name></person-group><article-title>The M<sub>2</sub> muscarinic receptor mediates contraction through indirect mechanisms in mouse urinary bladder</article-title><source>J Pharmacol Exp Ther</source><year>2005</year><volume>313</volume><fpage>368</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1124/jpet.104.077909</pub-id></citation><citation citation-type="display-unstructured">Ehlert FJ, Griffin MT, Abe DM, Vo TH, Taketo MM, Manabe T, Matsui M (2005) The M2 muscarinic receptor mediates contraction through indirect mechanisms in mouse urinary bladder. J Pharmacol Exp Ther 313:368&#x02013;378 <pub-id pub-id-type="pmid">15608083</pub-id></citation></ref><ref id="CR11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esqueda</surname><given-names>EE</given-names></name><name><surname>Gerstin</surname><given-names>EH</given-names><suffix>Jr</suffix></name><name><surname>Griffin</surname><given-names>MT</given-names></name><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>Stimulation of cyclic AMP accumulation and phosphoinositide hydrolysis by M<sub>3</sub> muscarinic receptors in the rat peripheral lung</article-title><source>Biochem Pharmacol</source><year>1996</year><volume>52</volume><fpage>643</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(96)00339-5</pub-id></citation><citation citation-type="display-unstructured">Esqueda EE, Gerstin EH Jr, Griffin MT, Ehlert FJ (1996) Stimulation of cyclic AMP accumulation and phosphoinositide hydrolysis by M3 muscarinic receptors in the rat peripheral lung. Biochem Pharmacol 52:643&#x02013;658 <pub-id pub-id-type="pmid">8759038</pub-id></citation></ref><ref id="CR12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>MT</given-names></name><name><surname>Hsu</surname><given-names>JC-H</given-names></name><name><surname>Shehnaz</surname><given-names>D</given-names></name><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>Comparison of pharmacological antagonism of M<sub>2</sub> and M<sub>3</sub> muscarinic receptors expressed in isolation and in combination</article-title><source>Biochem Pharmacol</source><year>2003</year><volume>65</volume><fpage>1227</fpage><lpage>1241</lpage><pub-id pub-id-type="doi">10.1016/S0006-2952(03)00068-6</pub-id></citation><citation citation-type="display-unstructured">Griffin MT, Hsu JC-H, Shehnaz D, Ehlert FJ (2003) Comparison of pharmacological antagonism of M2 and M3 muscarinic receptors expressed in isolation and in combination. Biochem Pharmacol 65:1227&#x02013;1241 <pub-id pub-id-type="pmid">12694864</pub-id></citation></ref><ref id="CR13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>MT</given-names></name><name><surname>Matsui</surname><given-names>M</given-names></name><name><surname>Shehnaz</surname><given-names>D</given-names></name><name><surname>Ansari</surname><given-names>KZ</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Manabe</surname><given-names>T</given-names></name><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>Muscarinic agonist-mediated heterologous desensitization in isolated ileum requires activation of both muscarinic M<sub>2</sub> and M<sub>3</sub> receptors</article-title><source>J Pharmacol Exp Ther</source><year>2004</year><volume>308</volume><fpage>339</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1124/jpet.103.055327</pub-id></citation><citation citation-type="display-unstructured">Griffin MT, Matsui M, Shehnaz D, Ansari KZ, Taketo MM, Manabe T, Ehlert FJ (2004) Muscarinic agonist-mediated heterologous desensitization in isolated ileum requires activation of both muscarinic M2 and M3 receptors. J Pharmacol Exp Ther 308:339&#x02013;349 <pub-id pub-id-type="pmid">14563784</pub-id></citation></ref><ref id="CR14"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>R</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Sperelakis NKuriyama</surname><given-names>H</given-names></name></person-group><article-title>Ion channels involved in responses to muscarinic receptor activation in smooth muscle</article-title><source>Ion channels of vascular smooth muscle cells and endothelial cells</source><year>1991</year><publisher-loc>New York</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>81</fpage><lpage>91</lpage></citation><citation citation-type="display-unstructured">Inoue R (1991) Ion channels involved in responses to muscarinic receptor activation in smooth muscle. In: Sperelakis NKuriyama H (ed) Ion channels of vascular smooth muscle cells and endothelial cells. Elsevier, New York, pp 81&#x02013;91 </citation></ref><ref id="CR15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitazawa</surname><given-names>T</given-names></name><name><surname>Hirama</surname><given-names>R</given-names></name><name><surname>Masunaga</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Asakawa</surname><given-names>K</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Teraoka</surname><given-names>H</given-names></name><name><surname>Unno</surname><given-names>T</given-names></name><name><surname>Komori</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Wess</surname><given-names>J</given-names></name><name><surname>Taneike</surname><given-names>T</given-names></name></person-group><article-title>Muscarinic receptor subtypes involved in carbachol-induced contraction of mouse uterine smooth muscle</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><year>2008</year><volume>377</volume><fpage>503</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1007/s00210-007-0223-1</pub-id></citation><citation citation-type="display-unstructured">Kitazawa T, Hirama R, Masunaga K, Nakamura T, Asakawa K, Cao J, Teraoka H, Unno T, Komori S, Yamada M, Wess J, Taneike T (2008) Muscarinic receptor subtypes involved in carbachol-induced contraction of mouse uterine smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 377:503&#x02013;513 <pub-id pub-id-type="pmid">18071676</pub-id></citation></ref><ref id="CR16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kotlikoff</surname><given-names>MI</given-names></name><name><surname>Kume</surname><given-names>H</given-names></name><name><surname>Tomasic</surname><given-names>M</given-names></name></person-group><article-title>Muscarinic regulation of membrane ion channels in airway smooth muscle cells</article-title><source>Biochem Pharmacol</source><year>1992</year><volume>43</volume><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(92)90652-Y</pub-id></citation><citation citation-type="display-unstructured">Kotlikoff MI, Kume H, Tomasic M (1992) Muscarinic regulation of membrane ion channels in airway smooth muscle cells. Biochem Pharmacol 43:5&#x02013;10 <pub-id pub-id-type="pmid">1370898</pub-id></citation></ref><ref id="CR17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>M</given-names></name><name><surname>Motomura</surname><given-names>D</given-names></name><name><surname>Karasawa</surname><given-names>H</given-names></name><name><surname>Fujikawa</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Komiya</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name></person-group><article-title>Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M<sub>3</sub> subtype</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><volume>97</volume><fpage>9579</fpage><lpage>9584</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.17.9579</pub-id></citation><citation citation-type="display-unstructured">Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, Takahashi S, Taketo MM (2000) Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci U S A 97:9579&#x02013;9584 <pub-id pub-id-type="pmid">10944224</pub-id></citation></ref><ref id="CR18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>M</given-names></name><name><surname>Motomura</surname><given-names>D</given-names></name><name><surname>Fujikawa</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Manabe</surname><given-names>T</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name></person-group><article-title>Mice lacking M<sub>2</sub> and M<sub>3</sub> muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable</article-title><source>J Neurosci</source><year>2002</year><volume>22</volume><fpage>10627</fpage><lpage>10632</lpage></citation><citation citation-type="display-unstructured">Matsui M, Motomura D, Fujikawa T, Jiang J, Takahashi S, Manabe T, Taketo MM (2002) Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J Neurosci 22:10627&#x02013;10632 <pub-id pub-id-type="pmid">12486155</pub-id></citation></ref><ref id="CR19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noronha-Blob</surname><given-names>L</given-names></name><name><surname>Lowe</surname><given-names>V</given-names></name><name><surname>Patton</surname><given-names>A</given-names></name><name><surname>Canning</surname><given-names>B</given-names></name><name><surname>Costello</surname><given-names>D</given-names></name><name><surname>Kinnier</surname><given-names>WJ</given-names></name></person-group><article-title>Muscarinic receptors: relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder</article-title><source>J Pharmacol Exp Ther</source><year>1989</year><volume>249</volume><fpage>843</fpage><lpage>851</lpage></citation><citation citation-type="display-unstructured">Noronha-Blob L, Lowe V, Patton A, Canning B, Costello D, Kinnier WJ (1989) Muscarinic receptors: relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder. J Pharmacol Exp Ther 249:843&#x02013;851 <pub-id pub-id-type="pmid">2543813</pub-id></citation></ref><ref id="CR20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ostrom</surname><given-names>RS</given-names></name><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>M<sub>2</sub> muscarinic receptors inhibit forskolin- but not isoproterenol-mediated relaxation in bovine tracheal smooth muscle</article-title><source>J Pharmacol Exp Ther</source><year>1998</year><volume>286</volume><fpage>234</fpage><lpage>242</lpage></citation><citation citation-type="display-unstructured">Ostrom RS, Ehlert FJ (1998) M2 muscarinic receptors inhibit forskolin- but not isoproterenol-mediated relaxation in bovine tracheal smooth muscle. J Pharmacol Exp Ther 286:234&#x02013;242 <pub-id pub-id-type="pmid">9655865</pub-id></citation></ref><ref id="CR21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ostrom</surname><given-names>RS</given-names></name><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>Comparison of functional antagonism between isoproterenol and M<sub>2</sub> muscarinic receptors in guinea pig ileum and trachea</article-title><source>J Pharmacol Exp Ther</source><year>1999</year><volume>288</volume><fpage>969</fpage><lpage>976</lpage></citation><citation citation-type="display-unstructured">Ostrom RS, Ehlert FJ (1999) Comparison of functional antagonism between isoproterenol and M2 muscarinic receptors in guinea pig ileum and trachea. J Pharmacol Exp Ther 288:969&#x02013;976 <pub-id pub-id-type="pmid">10027833</pub-id></citation></ref><ref id="CR22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ringdahl</surname><given-names>B</given-names></name></person-group><article-title>Determination of dissociation constants and relative efficacies of oxotremorine analogs at muscarinic receptors in the guinea-pig ileum by pharmacological procedures</article-title><source>J Pharmacol Exp Ther</source><year>1984</year><volume>229</volume><fpage>199</fpage><lpage>206</lpage></citation><citation citation-type="display-unstructured">Ringdahl B (1984) Determination of dissociation constants and relative efficacies of oxotremorine analogs at muscarinic receptors in the guinea-pig ileum by pharmacological procedures. J Pharmacol Exp Ther 229:199&#x02013;206 <pub-id pub-id-type="pmid">6707935</pub-id></citation></ref><ref id="CR23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roffel</surname><given-names>AF</given-names></name><name><surname>Meurs</surname><given-names>H</given-names></name><name><surname>Elzinga</surname><given-names>CR</given-names></name><name><surname>Zaagsma</surname><given-names>J</given-names></name></person-group><article-title>Characterization of the muscarinic receptor subtype involved in phosphoinositide metabolism in bovine tracheal smooth muscle</article-title><source>Brit J Pharmacol</source><year>1990</year><volume>99</volume><fpage>293</fpage><lpage>296</lpage></citation><citation citation-type="display-unstructured">Roffel AF, Meurs H, Elzinga CR, Zaagsma J (1990) Characterization of the muscarinic receptor subtype involved in phosphoinositide metabolism in bovine tracheal smooth muscle. Brit J Pharmacol 99:293&#x02013;296 <pub-id pub-id-type="pmid">2158372</pub-id></citation></ref><ref id="CR24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>T</given-names></name><name><surname>Unno</surname><given-names>T</given-names></name><name><surname>Kitazawa</surname><given-names>T</given-names></name><name><surname>Taneike</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Wess</surname><given-names>J</given-names></name><name><surname>Nishimura</surname><given-names>M</given-names></name><name><surname>Komori</surname><given-names>S</given-names></name></person-group><article-title>Three distinct muscarinic signalling pathways for cationic channel activation in mouse gut smooth muscle cells</article-title><source>J Physiol</source><year>2007</year><volume>582</volume><fpage>41</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2007.133165</pub-id></citation><citation citation-type="display-unstructured">Sakamoto T, Unno T, Kitazawa T, Taneike T, Yamada M, Wess J, Nishimura M, Komori S (2007) Three distinct muscarinic signalling pathways for cationic channel activation in mouse gut smooth muscle cells. J Physiol 582:41&#x02013;61 <pub-id pub-id-type="pmid">17463038</pub-id></citation></ref><ref id="CR25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sawyer</surname><given-names>GW</given-names></name><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>Contractile role of the M<sub>2</sub> and M<sub>3</sub> muscarinic receptors in the guinea pig colon</article-title><source>J Pharmacol Exp Ther</source><year>1998</year><volume>284</volume><fpage>269</fpage><lpage>277</lpage></citation><citation citation-type="display-unstructured">Sawyer GW, Ehlert FJ (1998) Contractile role of the M2 and M3 muscarinic receptors in the guinea pig colon. J Pharmacol Exp Ther 284:269&#x02013;277 <pub-id pub-id-type="pmid">9435187</pub-id></citation></ref><ref id="CR26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>EA</given-names></name><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>Involvement of the M<sub>2</sub> muscarinic receptor in contractions of the guinea pig trachea, guinea pig esophagus and rat fundus</article-title><source>Biochem Pharmacol</source><year>1996</year><volume>51</volume><fpage>779</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(95)02396-8</pub-id></citation><citation citation-type="display-unstructured">Thomas EA, Ehlert FJ (1996) Involvement of the M2 muscarinic receptor in contractions of the guinea pig trachea, guinea pig esophagus and rat fundus. Biochem Pharmacol 51:779&#x02013;788 <pub-id pub-id-type="pmid">8602873</pub-id></citation></ref><ref id="CR27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>EA</given-names></name><name><surname>Hsu</surname><given-names>HH</given-names></name><name><surname>Griffin</surname><given-names>MT</given-names></name><name><surname>Hunter</surname><given-names>AL</given-names></name><name><surname>Luong</surname><given-names>T</given-names></name><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>Conversion of <italic>N</italic>-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues</article-title><source>Mol Pharmacol</source><year>1992</year><volume>41</volume><fpage>718</fpage><lpage>726</lpage></citation><citation citation-type="display-unstructured">Thomas EA, Hsu HH, Griffin MT, Hunter AL, Luong T, Ehlert FJ (1992) Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues. Mol Pharmacol 41:718&#x02013;726 <pub-id pub-id-type="pmid">1569923</pub-id></citation></ref><ref id="CR28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>EA</given-names></name><name><surname>Baker</surname><given-names>SA</given-names></name><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>Functional role for the M<sub>2</sub> muscarinic receptor in smooth muscle of guinea pig ileum</article-title><source>Mol Pharmacol</source><year>1993</year><volume>44</volume><fpage>102</fpage><lpage>110</lpage></citation><citation citation-type="display-unstructured">Thomas EA, Baker SA, Ehlert FJ (1993) Functional role for the M2 muscarinic receptor in smooth muscle of guinea pig ileum. Mol Pharmacol 44:102&#x02013;110 <pub-id pub-id-type="pmid">8393516</pub-id></citation></ref><ref id="CR29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>JA</given-names></name><name><surname>Chang</surname><given-names>A</given-names></name><name><surname>Matsui</surname><given-names>M</given-names></name><name><surname>Ehlert</surname><given-names>FJ</given-names></name></person-group><article-title>Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M<sub>2</sub> and M<sub>3</sub> muscarinic receptors</article-title><source>Mol Pharmacol</source><year>2009</year><volume>75</volume><fpage>381</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1124/mol.108.051276</pub-id></citation><citation citation-type="display-unstructured">Tran JA, Chang A, Matsui M, Ehlert FJ (2009) Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors. Mol Pharmacol 75:381&#x02013;396 <pub-id pub-id-type="pmid">18996972</pub-id></citation></ref><ref id="CR30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Unno</surname><given-names>T</given-names></name><name><surname>Matsuyama</surname><given-names>H</given-names></name><name><surname>Sakamoto</surname><given-names>T</given-names></name><name><surname>Uchiyama</surname><given-names>M</given-names></name><name><surname>Izumi</surname><given-names>Y</given-names></name><name><surname>Okamoto</surname><given-names>H</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Wess</surname><given-names>J</given-names></name><name><surname>Komori</surname><given-names>S</given-names></name></person-group><article-title>M(2) and M(3) muscarinic receptor-mediated contractions in longitudinal smooth muscle of the ileum studied with receptor knockout mice</article-title><source>Br J Pharmacol</source><year>2005</year><volume>146</volume><fpage>98</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0706300</pub-id></citation><citation citation-type="display-unstructured">Unno T, Matsuyama H, Sakamoto T, Uchiyama M, Izumi Y, Okamoto H, Yamada M, Wess J, Komori S (2005) M(2) and M(3) muscarinic receptor-mediated contractions in longitudinal smooth muscle of the ileum studied with receptor knockout mice. Br J Pharmacol 146:98&#x02013;108 <pub-id pub-id-type="pmid">15965495</pub-id></citation></ref></ref-list></back></article> 